Atossa Genetics (ATOS) Stock: Gaining On Coming Presentation

Atossa Genetics Inc (NASDAQ: ATOS) is having an overwhelmingly strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced that it would be providing a presentation relatively soon, leading to excitement among investors. Today, we’ll talk about the news, what we’re seeing from the stock, and what we’ll be watching for with regard to ATOS ahead.

ATOS Gains On Coming Presentation 

As mentioned above, Atossa Genetics is having an overwhelmingly strong start to the trading session in the pre-market hours this morning after announcing a coming presentation. In a press release issued early this morning, the company announced that it would be presenting at the Adoptive T-Cell Therapy Symposium held during the 25th Annual Molecular Medicine Tri-Conference.




According to the release by ATOS, the presentation will be held on February 15th at 4:15 p.m. The presentation is titled “TRAP Car-T and Related Cell Therapies: Can Local Delivery Solve Efficacy and Toxicity Challenges in Solid Tumor Immuno-Oncology?” This presentation is designed to discuss the company’s proprietary intraductal microcatheter technology and the technology’s potential to deliver T-Cell and other immunotherapies directly to breast cancer tumors.

According to the release, Janet Rea, MSPH, RAC, Senior Vice President of Regulatory, Quality and Clinical Affairs at ATOS, will be the presenter. Ms. Rea joined ATOS back in 2015 and has over 35 years of industry experience.

What We’re Seeing From The Stock 

As investors one of the first lessons we learn is that the news moves the market. In this particular case, the news was exciting. With a coming presentation, Atossa Genetics will provide a further understanding of data while having the opportunity to attract large investors to the stock. So, it’s no surprise to see that the stock is making a run for the top. Currently (8:54), ATOS is trading at $0.59 per share after a gain of $0.04 per share (7.88%) thus far today.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will continue to keep a close eye on ATOS. In particular, we’re interested in following the story surrounding the presentation and excited to attend. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!
* indicates required


Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!
* indicates required

Add Comment